Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

tallysomycin B

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
SummaryTwenty patients with advanced head and neck tumors were entered in a phase II trial of tallysomycin S10b given… Expand
  • table 2
  • table 1
1989
1989
The objective of this study was to compare the relative in vitro cytotoxicity of bleomycin to that of two newer-generation… Expand
  • figure 1
  • figure 2
1984
1984
Tallysomycin S10b, a biosynthetic derivative of tallysomycin B, was subjected to intravenous toxicologic studies in mice and dogs… Expand
1983
1983
In the present study the fibrogenic potential of intact bleomycins as well as their acetyldipeptide and terminal polyamine… Expand
1981
1981
Tallysomycin S10b is a biosynthetic derivative of tallysomycin B obtained by precursor amine-feeding fermentation. Tallysomycin… Expand
1979
1979
Antibodies were raised against a new antineoplastic agent, tallysomycin, for use in a radioimmunoassay. The assay was sensitive… Expand
1978
1978
The antitumor activity of tallysomycins A and B was determined in five experimental tumor systems in mice. Tallysomycins A and B… Expand